IL6 and Hepatic fibrosis: However, treatment with IL-6 prompts macrophages to secrete miR-223-enriched exosomes, reducing the expression of TAZ in liver cells via exosomal transfer, ultimately contributing to the attenuation of liver fibrosis in mice induced by HFD (87).